Indomethacin does not attenuate the hypotensive effect of captopril, a converting enzyme inhibitor in Goldblatt hypertensive rats. 1981

K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534

Related Publications

K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
November 1996, Journal of human hypertension,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
April 1985, British journal of clinical pharmacology,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
January 2021, International journal of medical sciences,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
February 1980, Japanese journal of pharmacology,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
January 1980, British journal of pharmacology,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
April 1988, Medicina clinica,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
June 1981, Archives des maladies du coeur et des vaisseaux,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
November 1985, Japanese journal of pharmacology,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
November 1982, Japanese circulation journal,
K Omata, and Y Otsuka, and S Chiba, and T Itoh, and T Gotoh, and Y Imai, and Y Sakurai, and M Satoh, and T Haruyama, and M Hiwatari, and K Satoh, and A Kaitoh, and K Abe, and K Yoshinaga
November 1980, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!